cardiomyopeptidin

DRUG2 trials

Sponsors

Dalian Zhen-Ao Bio-Tech Co., Ltd., Chinese PLA General Hospital

Conditions

Cardiovascular DiseasesLeft Ventricular Ejection FractionSurvival Myocardial Area After Acute Myocardial Death

Phase 4

Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI

Dalian Zhen-Ao Bio-Tech Co., Ltd.Left Ventricular Ejection Fraction, Survival Myocardial Area After Acute Myocardial Death

Start: 2019-06-01End: 2020-01-31Target: 160Updated: 2019-05-22

A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI

CompletedNCT06155110

Chinese PLA General HospitalCardiovascular Diseases

Start: 2019-11-01End: 2025-05-01Updated: 2025-05-22